Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch.

Johnstone EC, Yudkin PL, Hey K, Roberts SJ, Welch SJ, Murphy MF, Griffiths SE, Walton RT.

Pharmacogenetics. 2004 Feb;14(2):83-90.

PMID:
15077009
2.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
3.

'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.

Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, Moore D.

Health Technol Assess. 2008 Feb;12(2):iii-iv, ix-xi, 1-135. Review.

4.

Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases.

Quaak M, van Schayck CP, Knaapen AM, van Schooten FJ.

Mutat Res. 2009 Jul 10;667(1-2):44-57. doi: 10.1016/j.mrfmmm.2008.10.015. Epub 2008 Nov 5. Review.

PMID:
19028511
5.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
6.

Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour.

Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Comings DE.

Pharmacogenetics. 1995 Jun;5(3):121-41. Review.

PMID:
7550364
7.

Genetic variation in the dopamine pathway and smoking cessation.

David SP, Munafò MR.

Pharmacogenomics. 2008 Sep;9(9):1307-21. doi: 10.2217/14622416.9.9.1307. Review.

PMID:
18781857
8.

Genetic clues to the molecular basis of tobacco addiction and progress towards personalized therapy.

Walton R, Johnstone E, Munafò M, Neville M, Griffiths S.

Trends Mol Med. 2001 Feb;7(2):70-6. Review.

PMID:
11286758
9.

Genetic variation in dopaminergic reward in humans.

Stice E, Dagher A.

Forum Nutr. 2010;63:176-85. doi: 10.1159/000264405. Epub 2009 Nov 27. Review.

PMID:
19955785
10.

Pharmacogenetics of nicotine addiction: role of dopamine.

Herman AI, DeVito EE, Jensen KP, Sofuoglu M.

Pharmacogenomics. 2014 Feb;15(2):221-34. doi: 10.2217/pgs.13.246. Review.

Supplemental Content

Support Center